The development of recombinant mediator technology has yielded valuable profiles for key immune signaling molecules: IL-1A, IL-1B, IL-2, and IL-3. These engineered forms, meticulously created in laboratory settings, offer advantages like enhanced purity and controlled potency, allowing researchers to investigate their individual and combined eff… Read More